An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Name: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)
Published: 2024
License: Public Domain

HuidaGene Therapeutics Co., Ltd. · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

crispr gene-editing

duchenne muscular dystrophin (dmd), dmd, dystrophin, gene-editing, hg302, crispr, interventional, early_phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Related documents